[Federal Register Volume 86, Number 100 (Wednesday, May 26, 2021)]
[Notices]
[Pages 28369-28370]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-11105]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Novel and 
Exceptional Technology and Research Advisory Committee.
    The meeting will be held as a virtual meeting and is open to the 
public. Individuals who plan to view the virtual meeting and need 
special assistance or other reasonable accommodations to view the 
meeting should notify the Contact Person listed below in advance of the 
meeting. The meeting will be videocast and can be accessed from the NIH 
Videocasting and Podcasting website (http://videocast.nih.gov/).

    Name of Committee: Novel and Exceptional Technology and Research 
Advisory Committee.
    Date: June 25, 2021.
    Time: 1:00 p.m. to 3:30 p.m.
    Agenda: The Novel and Exceptional Technology and Research 
Advisory Committee (NExTRAC) will discuss the Draft Report of the 
Gene Drives in Biomedical Research Working Group and next steps for 
the Committee.
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Suite 750, Bethesda, MD 20892 (Virtual Meeting--Link for the meeting 
will be available at https://osp.od.nih.gov/biotechnology/main-nextrac/#meetings).
    Contact Person: Kinshasa Letts, Office of Science Policy, 
National Institutes of Health, 6705 Rockledge Drive, Suite 750, 
Bethesda, MD 20892, 301-496-9838, [email protected].

    To sign up to make an oral public comment, please submit your 
name, affiliation, and short description of the oral comment to the 
Contact Person listed above by 5:00 p.m. EDT, June 21, 2021. Sign up 
will be restricted to one sign up per email and oral comments will 
be limited to two minutes. Once all time slots are filled, only 
written comments will be accepted. Any interested person may file 
written comments by forwarding their statement to the Contact Person 
listed on this notice. The Contact Person should receive any written 
statements by 5:00 p.m. EDT, June 23, 2021.
    Information is also available on the NExTRAC web page: https://osp.od.nih.gov/biotechnology/main-nextrac/#meetings,

[[Page 28370]]

where an agenda and any additional information for the meeting will 
be posted when available. The Draft Report of the Gene Drives in 
Biomedical Research Working Group will be posted prior to the 
meeting. Please check this website for updates.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: May 20, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-11105 Filed 5-25-21; 8:45 am]
BILLING CODE 4140-01-P